Drug Shortage Report for GENTAMICIN(E)

Last updated on 2023-02-07 History
Report ID 179918
Drug Identification Number 02082152
Brand name GENTAMICIN(E)
Common or Proper name GENTAMICIN(E)
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) GENTAMICIN
Strength(s) 1.6MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50mL (JB0852P)
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-01-09
Actual start date 2023-01-09
Estimated end date 2023-02-06
Actual end date 2023-02-06
Shortage status Resolved
Updated date 2023-02-07
Company comments Baxter product Gentamicin Sulfate Injection in 0.9% Sodium Chloride Injection 1 mg / mL (100 mg / 100 mL) (JB0863) is available as a substitute if aligned with clinical practice.
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2023-02-07 English Compare
v7 2023-02-06 French Compare
v6 2023-02-06 English Compare
v5 2023-01-30 French Compare
v4 2023-01-30 English Compare
v3 2023-01-10 English Compare
v2 2023-01-05 French Compare
v1 2023-01-05 English Compare

Showing 1 to 8 of 8